The Screw In Knotless Anchor Market is benefiting from advances in surgical technology and growing demand for reliable soft-tissue fixation. The market reached USD 700 million in 2024 and is expected to expand to USD 1.2 billion by 2035, with a 4.4% CAGR during 2026–2035.

Healthcare applications are supported by increasing orthopedic procedures and the adoption of minimally invasive surgical approaches. Knotless anchors are used in procedures including rotator cuff repair, ligament reconstruction, meniscus repair, and cartilage-related interventions. Their ability to provide fixation without traditional knot tying can help streamline certain surgical workflows.

The competitive landscape includes Arthrex, Smith & Nephew, Stryker, Zimmer Biomet, DePuy Synthes, Medtronic, Integra LifeSciences, Conmed, Baxter International, and Orthofix. Companies are focusing on product performance, biocompatibility, ease of use, and specialized designs to strengthen their positions in orthopedic and sports medicine markets.

Regional opportunities extend beyond the established North American and European markets. Asia Pacific is expected to grow rapidly as healthcare infrastructure improves and orthopedic treatment becomes more accessible. Rising healthcare expenditure and a large patient population could make countries across the region increasingly attractive for medical-device manufacturers.

Looking ahead, the market could benefit from 3D printing, advanced composite materials, and bioabsorbable implants. Customized anchor designs may enable surgeons to address patient-specific anatomical requirements, while digital technologies could support postoperative rehabilitation and outcome monitoring. These innovations are expected to broaden the role of screw-in knotless anchors in modern orthopedic care.